Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1286
Point of Care Diagnostics Market is estimated to value over CAGR of over 11.2% during the forecast period 2022 to 2028. Growing incidences of persistent disorders along with a rise in the ageing population increases the base of consumers who are likely to get affected by various diseases steers the expansion of the global market size. As per the International Diabetes Federation (IDF), over 400 million adults worldwide were diagnosed with diabetes in 2018 and it is predicted to grow up to over 600 million cases by 2040. The POC glucose meters are substantially useful in the management of glycaemic levels that are to be observed patients suffering from diabetes. Moreover, the factors steering the POC testing or diagnostics market growth include an increase in the number of investments made by several foundations associated with the government. As per the report published in November 2018, the National Institute of Health (NIH) provided grants of over USD 7 million to the Massachusetts Medical Device Development Center to set up a centre. This centre prioritizes on helping investors who are into point of care technologies and products. The service decentralization of primary care in many regional markets and programs initiated by the government agencies, for instance, National Health Service, accelerate the growth of the segment. The National Science Foundation, on February 2018, awarded Houston’s Rice University with USD 10.0 million for developing a POC-based solution called mHealth device. Although, the home-based POC testing procedure is predicted to stand out as the fastest augmenting segment over the forecast period. The introduction of portable and economical POC-based products for early prevention and detection of diseases spur the insistence of home-based POC testing devices. Additionally, the emergence of POC in home arrangements has maintained the patient’s comfort level. Impact of COVID-19 on Point of Care Diagnostics Market: The University of Connecticut Health Center has developed a method based on CRISPR technology that can be used to detect diseases like COVID-19. This technology offers a highly specific, reliable and sensitive testing approach for diagnosing nuclei acid-based molecules. Furthermore, this method can be performed at room temperature, unlike the PCR-based methods, where a thermal cycler is required for maintaining temperature. But the current CRISPR detection technology requires multiple manual operations, separate amplification of nuclei acids in various reaction systems. These requirements complicate the tests, thereby risking of carrying contaminations owing to the transfer of amplified products. Key players included in the global point-of-care diagnostics industry are: Abbott, AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN, Quidel. Point of Care Diagnostics Market Segmentation: By Product • Glucose Monitoring Products o Strips o Meters o Lancets & Lancing Platform • Cardiometabolic Testing Products o Cardia Marker Testing Products o Blood Gas/Electrolytes Testing Products o HBA1C Testing Products • Infectious Disease Testing Products o HIV testing Products o Hepatitis C Testing Products o Sexually Transmitted Disease (STD) Testing Products o Healthcare-Associated Infection (HAI) Testing Products o Respiratory Infection Testing Products o Tropical Disease Testing Products o Other Infectious Disease testing Products • Coagulation Testing Products o PT/INR Testing Products o Activated Clotting Time (ACT/APTT) Testing Products • Pregnancy and Fertility Testing Products o Tumour/Cancer Marker Testing Products o Urinalysis Testing Products o Cholesterol Testing Products o Hematology testing Products o Drug-of-Abuse Testing Products o Fecal Occult Testing Products o Other POC Products By Platform Agglutination Assays Immunoassays Biosensors Dipsticks Lateral Flow Assays Microfluidics Molecular Diagnostics Solid Phase By Mode Prescription-Based Testing OTC Testing By End User Home Care/ Self Testing Physician Offices and Outpatient Centers Hospitals Research Laboratories Other End Users By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global market by product, by platform, by mode, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Growing incidences of persistent disorders along with a rise in the ageing population increases the base of consumers who are likely to get affected by various diseases steers the expansion of the global market size. As per the International Diabetes Federation (IDF), over 400 million adults worldwide were diagnosed with diabetes in 2018 and it is predicted to grow up to over 600 million cases by 2040. The POC glucose meters are substantially useful in the management of glycaemic levels that are to be observed patients suffering from diabetes.
Moreover, the factors steering the POC testing or diagnostics market growth include an increase in the number of investments made by several foundations associated with the government. As per the report published in November 2018, the National Institute of Health (NIH) provided grants of over USD 7 million to the Massachusetts Medical Device Development Center to set up a centre. This centre prioritizes on helping investors who are into point of care technologies and products.
The service decentralization of primary care in many regional markets and programs initiated by the government agencies, for instance, National Health Service, accelerate the growth of the segment. The National Science Foundation, on February 2018, awarded Houston’s Rice University with USD 10.0 million for developing a POC-based solution called mHealth device.
Although, the home-based POC testing procedure is predicted to stand out as the fastest augmenting segment over the forecast period. The introduction of portable and economical POC-based products for early prevention and detection of diseases spur the insistence of home-based POC testing devices. Additionally, the emergence of POC in home arrangements has maintained the patient’s comfort level. Impact of COVID-19 on Point of Care Diagnostics Market:
The University of Connecticut Health Center has developed a method based on CRISPR technology that can be used to detect diseases like COVID-19. This technology offers a highly specific, reliable and sensitive testing approach for diagnosing nuclei acid-based molecules. Furthermore, this method can be performed at room temperature, unlike the PCR-based methods, where a thermal cycler is required for maintaining temperature. But the current CRISPR detection technology requires multiple manual operations, separate amplification of nuclei acids in various reaction systems. These requirements complicate the tests, thereby risking of carrying contaminations owing to the transfer of amplified products.
Key players included in the global point-of-care diagnostics industry are:
Abbott, AccuBioTech, BioMérieux SA, Bio-Rad Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher, EKF Diagnostics, F. Hoffmann-La Roche, Instrumentation Laboratory, Johnson & Johnson, Nova, PTS Diagnostics, Sekisui Diagnostic, Siemens Healthineers, Sinocare Inc., Sysmex Corporation, Trinity Biotech, Trividia Health Inc., QIAGEN, Quidel.
Point of Care Diagnostics Market Segmentation:
By Product
• Glucose Monitoring Products o Strips o Meters o Lancets & Lancing Platform • Cardiometabolic Testing Products o Cardia Marker Testing Products o Blood Gas/Electrolytes Testing Products o HBA1C Testing Products • Infectious Disease Testing Products o HIV testing Products o Hepatitis C Testing Products o Sexually Transmitted Disease (STD) Testing Products o Healthcare-Associated Infection (HAI) Testing Products o Respiratory Infection Testing Products o Tropical Disease Testing Products o Other Infectious Disease testing Products • Coagulation Testing Products o PT/INR Testing Products o Activated Clotting Time (ACT/APTT) Testing Products • Pregnancy and Fertility Testing Products o Tumour/Cancer Marker Testing Products o Urinalysis Testing Products o Cholesterol Testing Products o Hematology testing Products o Drug-of-Abuse Testing Products o Fecal Occult Testing Products o Other POC Products
By Platform
By Mode
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3.Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Point of Care Diagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Point of Care Diagnostics Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Point of Care Diagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Point of Care Diagnostics Market , By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Glucose Monitoring Products 7.1.1. Strips 7.1.2. Meters 7.1.3. Lancets and Lancing Platform 7.2. Cardiometabolic Testing Products 7.2.1. Cardia Marker Testing Products 7.2.2. Blood Gas/ Electrolytes Testing Products 7.2.3. HBA1C Testing Products 7.3. Infectious Disease Testing Products 7.3.1. Influenza Testing Products 7.3.2. HIV Testing Products 7.3.3. Hepatitis C Testing Products 7.3.4. Sexually Transmitted Disease Testing Products 7.3.5. Healthcare Associated Infection Testing Products 7.3.6. Respiratory Infection Testing Products 7.3.7. Tropical Disease Testing Products 7.3.8. Other Infectious Disease Testing Products 7.4. Coagulation Testing Products 7.4.1. PT/INR Testing Products 7.4.2. Activated Clotting Time Testing Products 7.5. Pregnancy and Fertility Testing Products 7.6. Tumor/ Cancer Marker Testing Products 7.7. Urinalysis Testing Products 7.8. Cholesterol Testing Products 7.9. Hematology Testing Products 7.10. Drug-of-Abuse Testing Products 7.11. Fecal Occult Testing Products 7.12. Other POC Testing Products 8. Global Point of Care Diagnostics Market , By Platform Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Agglutination Assays 8.2. Immunoassays 8.3. Biosensors 8.4. Dipsticks 8.5. Lateral Flow Assays 8.6. Microfluidics 8.7. Molecular Diagnostics 8.8. Solid Phase 9. Global Point of Care Diagnostics Market , By Mode Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Prescription-Based Testing 9.2. OTC Testing 10. Global Point of Care Diagnostics Market , By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Home Care/ Self Testing 10.2. Physician Offices and Outpatient Centers 10.3. Hospitals 10.4. Research Laboratories 10.5. Other End Users 11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Switzerland 13.2.9.Rest of Western Europe 13.4. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. Singapore 14.2.4. India 14.2.5. Australia and New Zealand 14.2.6. ASEAN 14.2.7. South Korea 14.2.8. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 16.1 ABBOTT 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 ACCUBIOTECH 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 BIOMERIEUX SA 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 BIO RAD LABORATORIES 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 BECTON DICKINSON AND CO. 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 CHEMBIO DIAGNOSTICS 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 DANAHER 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 EKF DIAGNOSTICS 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 F-HOFFMANN LA ROCHE 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 INSTRUMENTATION LABORATORY 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 JOHNSON & JOHNSON 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 NOVA 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13 PTS DIAGNOSTICS 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14 SEKISUI DIAGNOSTICS 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15 SEIMENS HEALTHINEERS 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 17. Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics